Decursin increases ROS levels and upregulates ATF4, PERK, and CHOP, thereby enhancing the expression of DR5 and sensitizing cancer cells to TRAIL-induced apoptosis (Kim J. et al., 2016). This evidence concerns the gene EIF2AK3 and cancer.